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Objective: The purpose of this study was to identify clinical and nonclinical factors associated with failure to perform
carotid endarterectomy (CEA) in patients with clinically appropriate indications. We analyzed data from a prospective
cohort study performed at five Veterans Affairs medical centers. Patients were referred for carotid artery evaluation if they
had at least 50% stenosis in one carotid artery, had no history of CEA, and were independently classified preoperatively
as appropriate candidates for CEA, according to clinical criteria. The primary outcome was receipt of CEA within 6
months of evaluation. Data were collected by medical record review and interview regarding clinical status, and patient
and physician perception of the risks and benefits of CEA.
Results: Among clinically appropriate candidates for CEA, 66.8% (n  233) did not undergo the operation. Compared
with patients who did undergo CEA, a greater proportion of these patients had no symptoms (68.7% vs 45.7%; P < .001).
A twofold greater proportion of patients who did not undergo CEA were in the highest quartile of reported aversion to
surgery. Moreover, a fourfold greater proportion were perceived by their physicians to be at less than 5% risk for future
stroke without the operation, and more than a twofold greater proportion were believed to experience less than 5%
efficacy from the operation by their providers (P < .01). In multivariable analyses, four characteristics were significantly
associated with whether an appropriate candidate did not receive CEA: asymptomatic disease, less than 70% stenosis, high
expressed aversion to surgery score, and low (<5%) provider-perceived efficacy of the operation.
Conclusion: Among patients in the Veterans Affairs health care system who are clinically appropriate candidates for CEA,
those who did not receive the operation were less likely to have symptomatic disease or high-grade carotid artery stenosis,
but were more likely to report high aversion to surgery and to have a provider who believed CEA would not be efficacious.
(J Vasc Surg 2004;39:162-8.)
Over the last two decades there have been numerous
observational studies of the pattern of use of carotid end-
arterectomy (CEA).1-7 Concern about overuse of the pro-
cedure has been a primary motivation for these inquiries.
Although appropriateness was assessed differently, in gen-
eral these studies suggest that the proportion of CEA
procedures performed for appropriate reasons has increased
over time. However, underuse of a clinically appropriate
procedure is of equal concern as overuse. While overuse
appears to be a decreasing concern, existing reports provide
essentially no insight into either the proportion of patients
who are clinically appropriate candidates for the procedure
but never receive it or the reasons why such candidates do
not receive the procedure.
Multiple factors may influence whether a clinically ap-
propriate patient undergoes CEA. Patients may perceive
the risks of the operation to be greater than the anticipated
benefits, despite a physician’s recommendation for the op-
eration. Perception of risks may be a consequence of previ-
ous personal surgical experience or that of family or friends,
personal preferences regarding invasive procedures, trust in
the medical community and the patient’s personal provider,
and beliefs and attitudes about health status and life in
general.8 Similarly, despite clinical indications, the provider
may perceive that the overall risk-benefit ratio for a partic-
ular patient is too great to warrant the operation, may have
concerns about the efficacy of CEA in general, or may have
other beliefs and attitudes about the usefulness of this
surgical procedure.9
As a result of a study designed to assess the association
between patient race and receipt of CEA, we were able to
investigate why patients who are clinically appropriate for
CEA do not receive it. In this report we present findings
regarding patient and provider characteristics and percep-
tions regarding the risks and benefits of CEA, as well as the
association of these factors with receipt of CEA in appro-
priate candidates for this surgical procedure.
METHODS
Study design
This is a secondary analysis of data collected from
patients and providers at five Veterans Affairs (VA) Medical
Centers, in Atlanta, Ga; Durham, NC; Pittsburgh, Pa;
Richmond, Va; and St Louis, Mo.10 The purpose of the
original study was to understand racial differences in the use
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of CEA. As an observational study, no attempt was made to
standardize or otherwise modify the usual practice patterns
involved in evaluating a patient for CEA; interpreting im-
aging studies, including grading of stenosis; or determining
recommendations in light of the findings. Information for
the study was obtained from the paper and electronic
medical records, interviews with the patients, and a ques-
tionnaire survey of their providers. Potential patient partic-
ipants were identified at carotid ultrasonography or Dopp-
ler scanning, and enrolled if they met eligibility criteria.
Providers who were eligible for the study and were sent a
questionnaire were those who had ordered the noninvasive
imaging study. At all sites, these providers were also the
ones who discussed the results with the patient and deter-
mined the next steps, which could include referral to an-
other provider for further evaluation. All participating pa-
tients provided written informed consent. The study was
approved by the institutional review boards at the five
medical centers.
Study population
Between September 1, 1997, and September 30, 1999,
4677 patients who underwent carotid ultrasonography at
any of the five sites were screened for study eligibility. Of
these, 902 met study criteria; that is, they had at least one
carotid artery with 50% or greater stenosis, had not under-
gone previous CEA, were cognitively able to participate,
and were either African American or white (patients of
other race or ethnicity were excluded). As patients of the
Department of Veterans Affairs health care system, virtually
all were men. Seven hundred eight patients (78%) were
enrolled. Medical record review and ascertainment of
symptom status was completed for 89 of 91 black patients
(98%) and 607 of 617 white patients (97%) enrolled in the
study. Six-month follow-up contacts were complete for
662 of the 708 study patients (94%).
Of the 3969 patients who were not enrolled, 2726
(69%) were excluded because they had less than 50% steno-
sis in both carotid arteries, 577 patients (15%) had previ-
ously undergone CEA, 274 patients (7%) had poor mental
status, 46 patients (1%) were self-reported to be of race or
ethnicity other than white or black, and 152 patients (4%)
were excluded for other reasons. An additional 194 patients
(4% of those approached) who were otherwise eligible
refused to participate; 86% were white.
Candidate appropriateness for CEA
On the basis of a set of clinical parameters delineated by
the Rand Corporation (Santa Monica, Calif), each patient’s
preoperative appropriateness for CEA was determined in-
dependent of provider assessment. The clinical parameters,
determined by an expert panel, have high content validity
and high test-retest reliability, and are internally consistent
with survival estimates generated from decision-modeling
of CEA and recommendations from randomized con-
trolled trial findings.11-14 The clinical information used to
make these judgments was abstracted from the medical
record, and included symptoms such as transient ischemic
attack (TIA) or completed stroke, degree of ipsilateral and
contralateral carotid artery stenosis, and anticipated opera-
tive risk.
Of the 708 enrolled patients, for the study, we included
only the 349 patients (49%) who were appropriate candi-
dates for CEA, as determined by these objective, preoper-
ative criteria. Sixty-seven patients (9%) were determined to
be uncertain candidates, and the remaining patients (42%)
were judged inappropriate for CEA.
Outcome measures
The primary outcome was failure to undergo CEA
within 6 months of the diagnostic test, and was defined as a
dichotomous variable (1  no CEA, 0  CEA).
Key explanatory variables
The potential explanatory variables of interest were the
array of patient-based and provider-based factors that the-
oretically or empirically influence the decision-making pro-
cess regarding receipt of CEA. Patient-based factors in-
cluded patient preference for the operation (ie, aversion to
the surgery), trust in the physician, prior surgical experi-
ence, and perceived health-related quality of life. Provider-
based factors were perceived risks and benefits of CEA for
the specific patient, including overall preoperative risk, risk
for stroke without the operation, and anticipated efficacy of
CEA.
Patient-based factors
Patient aversion to CEA. To determine patient po-
tential aversion to CEA, we used responses to a modified
standard gamble scenario that had been previously tested in
another population of veterans evaluated for CEA.15 As-
sessment of aversion involves presenting the patient with
the hypothetical situation that he or she is at high risk for
stroke and that there are two treatments, CEA (described)
and a pain-free medication. The outcome of the therapies is
living another 10 years in the current health state, or death
where the risk of death from surgery is set at 5% and the risk
for death from the medication begins at 50%. Risk for death
from the medication is increased or decreased until the
patient is indifferent to the therapy used. The resulting
score reflects the excess likelihood of death that the patient
is willing to tolerate to avoid undergoing the operation,
with higher scores interpreted as indicating greater aversion
to surgery. The variable was dichotomized at the fourth
quartile, or highest level of aversion (0 first through third
quartiles vs 1  fourth quartile), on the basis of examina-
tion of the appropriate scale for modeling this variable.16
Trust in physician. To assess patient interpersonal
trust in the provider, we used the Trust in Physician scale,
an 11-item validated questionnaire.17,18 The referenced
provider was the provider who was responsible for directing
the patient’s evaluation for CEA, including ordering the
initial noninvasive tests, discussing the findings, and mak-
ing the recommendation regarding CEA.
Previous surgical experience. Inasmuch as previous
surgical experiences are associated with willingness to un-
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dergo future operations,15 this experience was determined
from patient self-report. A dichotomous variable was cre-
ated that had a value of 1 if the patient had undergone any
previous surgical operation, and a value of 0 otherwise.
Health-related quality of life. Because a patient’s
perceived quality of life may affect the decisions about
therapeutic recommendations involving surgery, we mea-
sured general health-related quality of life with the physical
health and mental health subdomains of the Medical Out-
comes Study SF-12.19 These subdomains were analyzed as
continuous variables.
Provider-based factors
Provider-based factors were derived from provider sur-
veys regarding their patients’ risk-benefit profiles for CEA.
At the visit, when results of the ultrasonographic examina-
tion were discussed, providers completed a survey of stan-
dard questions about the risks and efficacy of CEA for the
specific patient. The patient’s provider responded to the
survey for only 88% of patients. However, patients with
completed provider surveys were similar in virtually all
characteristics to those for whom data were not available.
Perceived operative risk. This variable represented
provider assessment of a given patient’s likely risk for stroke
or death within 30 days after undergoing CEA. This sub-
jectively determined risk was categorized into three clini-
cally meaningful categories, reflecting low risk (3%),
moderate risk (3%5%), and high risk (5%).20
Perceived risk for stroke without CEA. For this
variable, the provider specified his or her perception of the
patient’s risk for future stroke during the subsequent year if
CEA was not performed. The array of scores was catego-
rized into quartiles.
Perceived efficacy of CEA. For this variable, the pro-
vider specified his or her assessment of the efficacy of CEA
for the patient, as measured by the percentage reduction in
risk for stroke. On the basis of examination of the appro-
priate scale for modeling, this variable was dichotomized at
5%. However, the cutoff point is also consistent with clin-
ical trials indicating that avoidance of 5% risk for future
stroke warrants CEA.
Covariates. As primary covariates we used patient age,
race, neurologic status (asymptomatic disease, TIA, or
stroke) and objective operative risk. Objective operative
risk was determined through medical record abstraction
with the protocol developed by McCrory et al.21 Clinical
status was determined at the carotid ultrasonographic ex-
amination. Insufficient data were available for patients with
completed stroke for either subtyping or determining
severity.
Statistical analysis
The primary goal of the analysis was to examine associ-
ations between receipt of CEA and an a priori set of
variables with multiple logistic regression modeling. This
set included variables that represented clinical, demo-
graphic, and perceived risk-benefit domains. The first step
of the analysis examined bivariate relationships between
receipt of CEA and explanatory variables, with 2 analysis
when the explanatory variable was categorical and with t
test or Wilcoxon rank-sum test when the variable was
continuous.
Because of the limited sample size available for model-
ing, we further reduced the number of variables in the
model on the basis of empirical examination of the a priori
variable set.22 Because of the relatively high correlation
between provider-assessed measures, only one provider-
assessed measure, anticipated efficacy of CEA, was retained
for modeling. With regard to patient-based variables, initial
models did not detect a significant relationship between the
Charlson comorbidity measure and the outcome variable,
and estimated coefficients for other variables did not
change markedly in magnitude in comparison of models
with and without the comorbidity measure. We therefore
omitted the Charlson measure from the final model.
The next step of the analysis was focused on fitting and
assessing the final logistic regression model. Variables in
this model included site, race, age in years, baseline neuro-
logic status, carotid artery stenosis, operative risk, aversion
score, and provider-assessed efficacy of CEA. Age did not
satisfy linearity assumptions for the model (ie, linearity in
the logit), and was therefore categorized as younger than
65 years, 65 to 74 years, and older than 74 years, to allow
examination of differences in these clinically relevant age
categories.16 Provider-assessed efficacy also was not linear
in the logit, and was dichotomized at 5%. Interactions were
not assessed in the model, because of limitations in sample
size. Sensitivity analysis with a generalized estimating equa-
tions model was conducted to ascertain whether clustering
of providers affected model results.23 One variable, site,
was not included in this model, because providers were
nested within site. To ascertain whether missing data had
an effect on results, 10 data sets were multiply imputed with
PROC MI (SAS Institute, Cary, NC). Logistic regressions
were run for each of these 10 data sets, and parameter
estimates from these regressions were combined with
PROC MIANALYZE (SAS Institute). All statistical analy-
ses were conducted with Windows version 8.2 (SAS Insti-
tute).
RESULTS
Demographic and clinical profile. Among the 349
patients who were classified preoperatively as clinically ap-
propriate candidates for CEA, approximately two thirds (n
 233) did not undergo the operation during follow-up.
Those who did not undergo CEA differed in baseline
neurologic status and site of care (Table I). A significantly
greater proportion of patients who did not receive CEA had
asymptomatic disease, whereas a smaller proportion had
either TIA or completed stroke. Eighty-six percent of pa-
tients with TIA and 46% of patients with previous stroke
had been evaluated within 120 days of the neurologic
event.
A provider could be identified for 329 of the 349
patients who were clinically appropriate candidates for
CEA. Among the 121 identified providers were 9 cardiol-
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ogists, 11 neurologists, 31 general internists, 8 other med-
ical specialists, 12 vascular surgeons, 9 other surgical spe-
cialists, 9 physician assistants, and 8 nurse practitioners; 24
providers did not list their specialty. Participating providers
had 1 to 51 patients under their care among the patients
included in this secondary analysis.
Patient-based factors that influence the decision for
CEA. Only one patient-based attitude or belief was asso-
ciated with not receiving CEA despite clinical appropriate-
ness (Table II). Those who did not undergo CEA reported
greater aversion to CEA, with approximately twice as many
patients reporting scores in the highest quartile as com-
pared with clinically appropriate patients who subsequently
underwent CEA. However, there was indication that pa-
tient refusal of the surgical procedure accounted for only
2.6% of patients who did not undergo CEA.
Provider-based factors that influence the decision
for CEA. Overall, providers recommended CEA in 106
patients (30.4%) who had been classified independently as
appropriate candidates. In the remaining patients, the pro-
vider believed that the overall potential benefits of the
operation were outweighed by the risks (n  29), the
patient required further examination or the provider be-
lieved the decision should be deferred to a specialist (n 
79), or the operation was believed to be unwarranted on
the basis of imaging findings (n  94). In 41 patients the
recommendation of the provider could not be determined
because the provider did not return the survey. However,
characteristics of these patients were similar to those of
patients whose provider did return a survey.
Physician perception of patient risk for future stroke
and of the efficacy of CEA was associated with having the
operation (Table III). Greater proportions of clinically
appropriate candidates who did not undergo CEA were
classified in the lowest quartile of physician-perceived risk
for stroke for the patient if he or she did not undergo CEA
and provider-perceived efficacy of the operation was less
than 5%. Among patients who underwent CEA, providers
perceived that the patient was at greater risk for stroke
without the operation and would experience greater effi-
cacy of the operation if received.
The level of provider-perceived operative risk for the
patient was not associated with who did or did not receive
CEA. Of note, the level of preoperative risk as determined
with the McCrory index and that of the provider were
correlated, but not perfectly. Thus 34% (n  69) of 206
patients who were rated at low risk with the McCrory index
were rated at high risk by the physician, whereas 63% (n 
52) of 83 patients categorized at high risk with the Mc-
Crory index were judged at lower risk by physicians.
Multivariable model results. After adjustment for
covariates, several patient characteristics were important
determinants of whether an appropriate candidate did not
undergo CEA (Table IV). These characteristics included
symptom-free disease, less than 70% stenosis, expressed
aversion to surgery that was in the highest quartile of
Table I. Demographic and clinical characteristics of
patients who are appropriate candidates for CEA
according to receipt of CEA
Characteristic
No CEA
(n  233)
CEA
(n  116) P*
Demographic
Mean age (y) SD 69.6, 7.7 68.1, 8.1 .11
Black (%) 11.6 9.5 .59
Education 12 y (%) 61.5 63.5 .73
Live alone (%) 24.0 26.1 .69
Enrolled as inpatient (%) 15.9 29.6 .004
Clinical
Neurologic status (%) .001
Asymptomatic 68.7 45.7
Transient ischemic attack 18.0 33.6
Stroke 13.3 20.7
Carotid artery stenosis
70%-99% (%)
90.1 94.0 .31
Comorbidity (%)
Hypertension 85.4 78.5 .13
Cardiac disease (MI, AFib) 42.5 37.1 .36
Diabetes with end-organ
damage
17.6 23.3 .25
Diabetes without end-
organ damage
17.2 18.1 .88
Peripheral vascular disease 40.8 40.5 1.00
Median Charlson index score
IQR
2.0, 2.0 2.0, 2.0 .89
Low operative risk
(McCrory Index)
24.5 34.5 .06
Site (%) .001
1 6.0 21.6
2 18.5 13.8
3 27.0 25.0
4 15.5 10.3
5 33.0 29.3
CEA, Carotid endarterectomy; MI, myocardial infarction; AFib, atrial fibril-
lation; SD, standard deviation; IQR, interquartile range.
*Pearson 2, Wilcoxon rank-sum, or t-test.
Table II. Patient-based factors that may influence
decision to undergo CEA among patients who are
appropriate candidates for CEA
Characteristic
No CEA
(n  233)
CEA
(n  116) P*
Aversion to CEA score (%)† .01
0.00-0.25 76.1 88.3
0.35-0.95 23.9 11.7
Median trust in physician 1.7 1.7 .90
IQR‡ 1.0 0.9
Previous surgical operations (%) 85.0 87.9 .52
Median physical health–related
quality of life
38.6 36.7 .16
IQR§ 17.8 18.5
Median mental health–related
quality of life
55.6 55.6 .45
IQR§ 11.5 12.5
CEA, Carotid endarterectomy; IQR, interquartile range.
*Pearson 2 or Wilcoxon rank-sum test.
†Higher score indicates greater aversion.
‡Lower score indicates more trust.
§Higher score indicates higher quality of life.
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scores, and low (5%) provider-perceived efficacy of the
operation. Among study sites, at only one did the relative
odds of appropriate candidates not receiving the operation
differ such that relatively few appropriate candidates did not
undergo the operation. Sensitivity analyses confirmed that
neither clustering nor missing data affected model results.
DISCUSSION
We have documented that certain clinical features and
patient reported level of aversion to surgery are significantly
associated with whether a clinically appropriate candidate
for CEA ultimately undergoes the operation. Specifically,
patients who are symptom-free, have carotid artery stenosis
less than 70%, are perceived by the provider as likely to
experience low efficacy from the operation, and are more
averse to surgery have a lower likelihood of subsequently
undergoing CEA despite being clinically appropriate can-
didates.
These findings were derived from an observational
study of actual practice patterns related to use of CEA.
Previous observational studies have focused on the clinical
characteristics of patients who undergo CEA, and specifi-
cally on the proportion of patients who are appropriate,
inappropriate, or uncertain candidates for the operation.1-7
Findings from these studies suggest that an increasing
proportion of patients receiving CEA are appropriate can-
didates for the procedure, diminishing concerns about its
possible overuse. By contrast, we examined potential unde-
ruse of the operation, an area that has not been well studied.
We found that a substantial proportion of clinically appro-
priate candidates (66.8%) do not undergo CEA.
It is interesting that the clinical characteristics associ-
ated with receipt of CEA when inappropriate are often
similar to those associated with failure to receive the oper-
ation when determined preoperatively to be appropriate.
That is, a recent report indicates that among the reasons a
patient inappropriately receives CEA is the presence of
minimal stenosis and extensive comorbidity.7 By compari-
son, we found that lower-grade stenosis and lack of symp-
toms were associated with not receiving CEA when the
patient is an appropriate candidate (as determined indepen-
dently of provider assessment).
Of significance, patient demographic factors and pa-
tient attitudes and beliefs about CEA (with the exception of
aversion to surgery) had little relationship to undergoing
CEA when appropriate. The finding of no association with
patient race is important, because a substantial racial differ-
ence has been reported in the use of CEA.24-27 There has
been particular concern that the patient-provider decision-
making process inappropriately excludes black patients
from CEA despite the appropriateness of the opera-
tion.15,28 Our findings provide further indication that less
use of CEA in black patients may be due, in part, to aversion
to surgery rather than to race per se.10,15
It is also notable that few of these candidates who were
appropriate for CEA refused to undergo the operation.
Moreover, provider perception of the efficacy of the oper-
ation for the patient was an important factor in whether the
Table IV. Adjusted odds ratio* of not receiving CEA,
associated with demographic and clinical characteristics of
patients who are clinically appropriate candidates for CEA
and provider-perceived risks and benefits of CEA
Characteristic OR 95% CI P
Demographic
Age (y) (referent  65 y) .26
65-74 1.8 0.9, 3.6
75 1.6 0.7, 3.6
Black (referent  white) 0.6 0.2, 1.6 .31
Clinical
Neurologic status (referent  TIA) .01
Stroke 1.7 0.7, 4.3
Asymptomatic 3.7 1.5, 9.1
70% Stenosis† (referent  70%) 3.2 1.1, 9.5 .04
Low McCrory index of operative
risk (referent  high)
1.1 0.5, 2.6 .75
Perceived risk and benefit
Aversion score, highest quartile
(referent  lower 3 quartiles)
2.3 1.0, 5.1 .04
Low (5.0%) efficacy of CEA
(referent  5.0%)
2.7 1.2, 5.9 .02
Other
VA facility (referent  Site 5) .03
Site 1 0.3 0.1, 0.8
Site 2 1.4 0.6, 3.4
Site 3 1.4 0.6, 3.1
Site 4 1.4 0.6, 3.3
CEA, Carotid endarterectomy; OR, odds ratio; CI, confidence interval;
TIA, transient ischemic attack.
*Multivariable logistic model included site, race, age in years, baseline
neurologic status, carotid artery stenosis, operative risk, aversion score, and
provider-assessed efficacy of CEA. C statistic for logistic regression model
0.73. Final n for adjusted model  253.
†Carotid artery stenosis of the artery deemed most appropriate according to
the RAND algorithm.
Table III. Provider-based factors that may influence
decision to undergo CEA among patients who are
appropriate candidates for CEA according to receipt of
CEA*
Perceived characteristic of patient
at carotid ultrasound study
No CEA
(n  198)
CEA
(n  110) P†
Operative risk .59
5.0% 36.1 32.1
3.0%-5.0% 30.1 35.9
0.0%-3.0% 33.9 32.1
Risk for stroke without CEA‡ .0001
15% 18.5 38.0
10%-15% 19.5 34.3
5%-10% 29.7 19.4
0%-5% 32.3 8.3
Efficacy of carotid
endarterectomy
.002
5.0% 71.7 88.5
5.0% 28.3 11.5
CEA, Carotid endarterectomy.
*Based on 88% of patients for whom provider returned the survey.
†Pearson 2 test.
‡Quartiles arranged from highest to lowest.
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patient subsequently received CEA. While these findings
suggest that physicians have the more dominant role in
determining the course of care, patients may not be without
influence in the decision-making process. Clearly, our find-
ings suggest that patient level of aversion to surgery is
involved in the final decision. Although we did not ascer-
tain whether patient aversion to surgery was overtly or
more subtly expressed to the physician, clinically appropri-
ate patients who reported the highest level of aversion to
surgery were less likely to undergo CEA, after adjustment
for other potential influences on the decision. This is an
area that may require further investigation to determine the
extent to which patient aversion to surgery influences the
final decision regarding CEA.
These findings and their interpretation need to be
considered with due regard for the limitations of the study.
This study was conducted within the Department of Vet-
erans Affairs health care system. This is an equal-access
system for eligible patients, and there are fewer cost con-
siderations for patients or physicians in use of health care.
That is, patients have minimal responsibility for the cost of
their care, and physicians have fewer financial incentives
regarding use of surgical procedures. Thus, the patterns
observed in this health care system may not reflect patterns
in other health care arrangements where cost may be a
factor. A related limitation is that patient use of health care
within the community was not assessed. Thus, appropriate
candidates who did not undergo CEA in VA facilities may
have received the surgery from their community provider.
Although the exact proportion is not known, we believe it
is minimal, especially for expensive procedures, given the
cost incentives associated with receiving care within the VA
system. A third potential limitation is that virtually all of the
patients were men. Men and women may differ in either
self-perceived or physician-perceived risks and benefits of
CEA. Hence the factors that we identified as associated
with receipt of CEA in clinically appropriate candidates may
differ in a general population. Another important limitation
is that patients were identified at the point of referral for
evaluation of carotid arteries. If there was patient selection
bias before this point, our cohort may not represent the
population of clinically appropriate candidates for CEA.
Again, this may bias the array of factors identified as impor-
tant influences on receipt of CEA.
With due regard for these limitations, we conclude that
among patients in the VA health care system who are
clinically appropriate candidates for CEA, those who actu-
ally undergo the operation are determined primarily by the
presence of definitive symptoms (TIA) and signs (high-
grade stenosis in the carotid artery), provider-perceived
efficacy of the operation for the patient, and patient inher-
ent aversion to the procedure.
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